Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-24 @ 5:41 PM
Ignite Modification Date: 2025-12-24 @ 5:41 PM
NCT ID: NCT02170168
Eligibility Criteria: Inclusion Criteria (Patients): * Advanced loco-regional disease and/or metastatic cancer disease * For the intervention group in the Orkdal region: Inhabitant of one of the following thirteen districts: Surnadal, Halsa, Rindal, Hemne, Orkdal, Frøya, Hitra, Snillfjord, Agdenes, Meldal, Rennebu, Skaun, and Oppdal * For the intervention group in the Romsdal region: Inhabitiant of one of the following nine districts: Aukra, Molde, Eide, Vestnes, Sunndal, Fræna, Midsund, Nesset, Rauma * Acceptance of participation, based on information about the study and that participation is voluntary. Documented by a signed consent form. * Able to comply with the study procedures * Able to read and write Norwegian Inclusion criteria (Carers) (a carer a person identified as such by the patient) * the patient is eligible for the study * the patient has given his or her consent to allow the study nurse to approach the carer to participate in the study * the patient has identified the carer to be approached * acceptance of participation, based on information about the study and that participation is voluntary. Documented by a signed consent form. Inclusion Criteria (Health care providers) * has accepted to participate in the study * Acceptance of participation, based on information about the study and that participation is voluntary. Documented by an electronically signed consent form. Exclusion Criteria (Patients): * Receiving anti-cancer treatment with curative intent Exclusion Criteria (Carers) * not able to complete the assessments
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT02170168
Study Brief:
Protocol Section: NCT02170168